Menu
ncarol.com
  • Home
  • Business
  • Health
  • Entertainment
  • Arts
  • Education
  • Technology
  • Real Estate
  • Non-profit
ncarol.com

National Brain Tumor Society to Launch Campaigns Elevating the Necessity of Clinical Trials and Biomarker Testing Access
ncarol.com/10235124

Trending...
  • Sober.Buzz the Sober Token : Ticker $BUZZ
  • DuoKey to Unveil Encrypted Financial Intelligence Use Case at GISEC Global 2025
  • myb.day Launches New Birthday Gift Shop Filled With Personalized Surprises
Joint initiatives aim to help patients and families navigate the era of precision medicine in cancer care

NEWTON, Mass. - ncarol.com -- National Brain Tumor Society (NBTS), a leader in brain tumor patient advocacy, research, information, and support, today announced the launch of two interrelated public health campaigns focused on patient awareness and access to advanced biomarker testing and clinical trials.

"While continued investment and concerted drug development efforts are certainly needed, the precision medicine era has arrived for patients with brain tumors," said David Arons, president and chief executive officer of NBTS. "With the World Health Organization's two recent reclassifications of central nervous system tumors in 2016 and 2021, patients with brain tumors need more precise diagnoses. These recent advances in the understanding of the molecular characteristics of tumor types, as well as new drug approvals and encouraging results from recent clinical trials, call for a greater understanding of patient options from the point of diagnosis. We want to ensure that brain tumors undergo comprehensive biomarker analysis and that patients and their care partners better understand and have improved access to clinical trials and expanded access options that might be their best source of care. To achieve this result, the NBTS campaigns will inform patients, seek improved coverage from insurers, and work with providers."

More on ncarol.com
  • Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
  • Cybersecurity is Protecting Your Personal Information and Your Portfolio
  • Matthew Glova, CFP® of LifeTime Asset Honored in Forbes Best-In-State Wealth Advisors2025
  • L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
  • Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success

NBTS is launching the campaigns based on data on educational gaps in the brain tumor community gathered via a broad survey. Data collection analysis will inform future strategies, in addition to already planned educational and engagement activities.

The campaigns are being launched and developed with the generous support from Bayer, Danaher Foundation, and Servier Pharmaceuticals.

About the National Brain Tumor Society

Building on over 30 years of experience, the National Brain Tumor Society (NBTS) unrelentingly invests in, mobilizes, and unites the brain tumor community to discover a cure, deliver effective treatments, and advocate for patients and caregivers. Our focus on defeating brain tumors and improving the quality of patients' lives is powered by our partnerships across science, healthcare, policy, and business sectors. We fund treatments-focused research and convene those most critical to curing brain tumors once and for all. Join us at BrainTumor.org.

Contact
Tom Halkin
National Brain Tumor Society
***@braintumor.org


Source: National Brain Tumor Society

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
  • Wall Street analysts say BTC.XRP.DOGE cloud mining company SIX MINING is expected to achieve a 5-fold increase, allowing users to easily mine BTC
  • Gen X Takes The Reins: New Book Guides Caregivers Juggling Parents, Kids, And Grandkids With Humor And Heart
  • Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
  • ABM for Good™ Launches First Project with Build Change
  • ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
  • Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
  • Jay Tapp was named Managing Director in British Columbia
  • Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
  • 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
  • NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
  • Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
  • DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
  • Costa Oil Racing and Rick Ware Racing Celebrate Back-to-Back Victories Across the Country
  • Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
  • Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
  • $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
  • Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban
  • Dr. Michael Matzinger Honored with Silver Antelope Award for Distinguished Service to Youth
  • xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
_catLbl0 _catLbl1

Popular on ncarol.com

  • 11th annual Florida Blueberry Festival April 26 & 27, 2025 - 169
  • Village Vapes and Cooking 4 Autism Announce Inaugural Partnership at MEGA 420 EVENT - 161
  • Perfect Body Laser & Aesthetics Launches New Website - 119
  • New Blog Post Shares the Ultimate List of Free Resources to Help Artists Make a Comic - 105
  • The Ultimate Med Spa Growth Engine: PatientNow and Aesthetix CRM Announce Strategic Integration - 101
  • North American Security Launches New Website to Reflect Evolving Industry Demands and Client-Centered Solutions
  • Rising Pop R&B Sensation Leon Zellers to Release New Single "Wanna Know" on April 11
  • The World's No.1 Superstar Champions the NO FAKES Act – Secures Global Identity and Cultural Legacy
  • 19th Annual High Performance Home Tour Will Feature Green Certified Homes Throughout The Triangle
  • Artist Séfora Camazano Honored with Prestigious Prize "The New Great Masters in New York"

Similar on ncarol.com

  • NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
  • Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
  • Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
  • ABM for Good™ Launches First Project with Build Change
  • ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
  • 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
  • Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
  • $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
  • Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban
  • Dr. Michael Matzinger Honored with Silver Antelope Award for Distinguished Service to Youth
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute